Advaxis Inc (NASDAQ:ADXS)

1.70
Delayed Data
As of Jun 21
 -0.04 / -2.30%
Today’s Change
1.51
Today|||52-Week Range
7.45
-40.14%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close1.74
Today’s open1.75
Day’s range1.69 - 1.76
Volume439,970
Average volume (3 months)845,859
Market cap$98.4M
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-11.06%
Earnings growth (this year)+26.52%
Earnings growth (next 5 years)--
Revenue growth (last year)+201.16%
P/E ratioNM
Price/Sales11.45
Price/Book1.43

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.44-5.35%
NERVMinerva Neuroscience...-0.30-3.33%
IMDZImmune Design Corp-0.30-6.32%
URGNUrogen Pharma Ltd-0.29-0.53%
Data as of 4:00pm ET, 06/21/2018

Financials

Next reporting dateSeptember 10, 2018
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$12.0M
Annual profit (last year)-$93.4M
Net profit margin-776.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ken Berlin
Chief Financial Officer &
Executive Vice President
Molly Henderson
Corporate headquarters
Princeton, New Jersey

Forecasts